By Roberto Camacho & Ron Krauskopf
Health systems have long used physician joint ventures to align incentives, expand access points, and scale outpatient growth. As these platforms mature, many organizations encounter a familiar challenge: how to fund the next phase of growth without slowing momentum.
The model works, physicians have skin in the game, governance is shared, and incentives are aligned, particularly in the early stages.
Where Joint Ventures Stall
Friction often emerges when a joint venture evolves from an anchor platform into a growth vehicle. As leadership looks to pursue additional acquisitions, the capital question quickly becomes more complex.
Health systems must commit incremental capital. Physician partners, meanwhile, face a more difficult decision: contribute personal liquidity or rely on equity holdback balances that may not yet be fully realized. In ventures with dozens of physician owners, capital calls can become exercises in consensus building, slowing or even stalling otherwise sound investment opportunities.
A Structural Solution: Financing at the Holding Company Level
There is another path, one rooted in a structural reality many health system executives understand but rarely apply in this context: the physician-owned holding company is a bankable entity.
In a recent transaction involving a multi-specialty physician platform within a health system joint venture, we structured a revolving credit facility directly to the physician-owned holding company that sits above the anchor entity. The health system was not a party to the loan. Repayment obligations remained solely with the physician owners, supported primarily by distributions flowing from the holding company.
Why It Matters for Health System Growth
This approach delivers two meaningful advantages, directly impacting speed to market, capital efficiency, and physician alignment.
First, structuring the facility at the holding company level keeps the financing outside of the joint venture’s regulatory framework. While distributions from the medical entity itself cannot be pledged as collateral, a direct lending relationship with the holding company effectively navigates that constraint. The health system is not a party, guarantor, or beneficiary of the loan. Instead, the bank underwrites the credit based on the strength and consistency of physician distributions, the quality of earnings, and the operator’s track record.
Secondly, and more practically, this structure removes one of the most significant barriers to scaling a joint venture platform. Health systems no longer need approval from large physician groups to fund each acquisition. At the same time, physicians are not required to draw on personal savings or wait for holdback distributions to participate in growth. Both parties preserve flexibility, and the platform becomes more agile in pursuing expansion opportunities.
In this case, the facility included a two-year draw period, allowing physicians to access capital as acquisition opportunities arose. At the end of the draw period, the structure converts to an amortizing term loan. By that point, the deployed capital is expected to have funded acquisitions that enhance earnings and strengthen the physician distribution stream—creating a reinforcing cycle in which growth capital supports the cash flow needed to service the debt.
A Strategic Consideration for Growth-Focused Systems
Health system strategy executives, outpatient leaders, and physician enterprise teams should consider this approach when evaluating how to fund joint venture expansion. While the banking relationship directly supports the physician side of the partnership, the broader strategic benefit accrues to the platform itself—and, by extension, the health system’s long-term growth strategy.
Not every bank has the healthcare expertise required to structure these facilities. It demands a deep understanding of physician practice economics, distribution mechanics, regulatory considerations, and the dynamics of physician-health system alignment. For organizations seeking to accelerate joint venture growth without introducing capital call friction, engaging the right banking partner can represent a meaningful strategic advantage.
Roberto Camacho is Head of Healthcare Banking at Provident Bank, and Ron Krauskopf is Head of Specialty Commercial Lending at Provident Bank. For more information, Roberto can be contacted at [email protected] or 732-513-2830.
This is not an extension of credit or commitment of financing. This is not a solicitation to participate in a specific transaction. Any opinions expressed are subject to change and may not reflect those of Provident Bank. Transactions discussed may involve risk. This article is for informational purposes only. Provident Bank does not provide tax, accounting, or legal advice. Please consult a professional regarding your specific situation.
The editorial staff had no role in this post's creation.